- Latest week
- 10 Jul 2026
- Close
- 0.043000
- Fair value
- 0.062562
- Next-week expectancy
- Undecided 45.35%
ADXN Chart Pack
Addex Therapeutics Ltd
Chart Summary
Over the latest 12 completed weeks ending 2026-07-10, ADXN fell 13.65%, moving from 0.05 to 0.04. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -26.44 and has softened across the 12-week window. Market Dynamics is 0.37 on the latest week. Next-week expectancy is undecided at 45.35% based on similar historical setup states.
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 0.04
- 12-Week Change
- -13.65%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Undecided 45.35%
- Signal Weeks
- 0 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Below
- Relative Strength
- -26.44
- Market Dynamics
- 0.37
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 0.04
- 12-Week Change
- -13.65%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Undecided 45.35%
- Signal Weeks
- 0 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Below
- Relative Strength
- -26.44
- Market Dynamics
- 0.37
Over the latest 12 completed weeks ending 2026-07-10, ADXN fell 13.65%, moving from 0.05 to 0.04. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -26.44 and has softened across the 12-week window. Market Dynamics is 0.37 on the latest week. Next-week expectancy is undecided at 45.35% based on similar historical setup states.
Industry Peers
Switzerland equities in Biotechnology
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| BIOV BioVersys AG | EBS | 10 Jul 2026 | 26.70 | 27.60 | 26.60 | 27.50 | 3.00% |
| SANN Santhera Pharmaceuticals Holding AG | EBS | 10 Jul 2026 | 14.82 | 16.30 | 14.42 | 15.22 | 2.70% |
| MOLN Molecular Partners AG | EBS | 10 Jul 2026 | 3.18 | 3.25 | 3.16 | 3.23 | 1.57% |
| BSLN Basilea Pharmaceutica AG | EBS | 10 Jul 2026 | 54.60 | 56.30 | 52.70 | 54.70 | 0.18% |
| BION BB Biotech AG | EBS | 10 Jul 2026 | 50.90 | 52.00 | 49.30 | 50.60 | -0.59% |
| XLS Xlife Sciences AG | EBS | 10 Jul 2026 | 18.40 | 18.90 | 17.55 | 18.15 | -1.36% |
| BANB Bachem Holding AG | EBS | 10 Jul 2026 | 78.00 | 79.15 | 71.70 | 74.85 | -4.04% |
| NWRN Newron Pharmaceuticals S.p.A. | EBS | 10 Jul 2026 | 12.32 | 12.36 | 11.72 | 11.80 | -4.22% |
| IDIA Idorsia Ltd | EBS | 10 Jul 2026 | 6.69 | 6.76 | 6.09 | 6.20 | -7.32% |
| MMTX MindMaze Therapeutics Holding SA | EBS | 10 Jul 2026 | 0.21 | 0.22 | 0.17 | 0.17 | -15.63% |